Skip to main content
Pharma Foods International Co., Ltd. logo

Pharma Foods International Co., Ltd. — Investor Relations & Filings

Ticker · 2929 ISIN · JP3802310007 T Manufacturing
Open in API
Filings indexed 66 across all filing types
Latest filing 2026-03-16 Regulatory Filings
Country JP Japan
Listing T 2929

About Pharma Foods International Co., Ltd.

https://www.pharmafoods.co.jp/en

Pharma Foods International Co., Ltd. is a research-driven company focused on developing food ingredients with scientifically-proven functions, guided by the mission to create products as effective as pharmaceuticals. The company's operations are centered on three core areas: immunity, aging, and the nervous system. Its business is structured into three main segments: the Functional Materials business, which develops and sells proprietary ingredients; the B2C business, which markets and sells supplements, cosmetics, and non-pharmaceutical products directly to consumers via e-commerce; and the Bio Medical business, which engages in drug discovery utilizing its proprietary ALAgene® antibody-production technology.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like a semi-annual report. H1 2026
2026-03-16 Japanese
半期報告書－第29期(2025/08/01－2026/07/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis (MDA), and business status updates for the interim period (August 1, 2025, to January 31, 2026). As it is a formal, comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2026
2026-03-16 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO regarding the accuracy of the Annual Securities Report (Yuuka Shouken Houkokusho). Since it is a regulatory filing required to accompany the annual report and does not fit into the specific categories of financial reports or announcements, it is classified as a Regulatory Filing (RNS). FY 2025
2025-10-21 Japanese
有価証券報告書－第28期(2024/08/01－2025/07/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the standard regulatory header, fiscal year information (28th term, 2024-08-01 to 2025-07-31), and extensive XBRL tagging for financial statements, confirming it is the full annual report rather than an announcement or summary. FY 2025
2025-10-21 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書" which translates to 'Report on the Status of Treasury Stock Acquisition'. The document explicitly cites the legal basis as '金融商品取引法第24条の６第１項' (Financial Instruments and Exchange Act Article 24-6, Paragraph 1). The content details the acquisition status of treasury stock ('自己株式') during a specific reporting period (May 1, 2025, to May 31, 2025). This type of filing, reporting on the company's own share transactions, directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is a report detailing the buyback activity, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2025-06-05 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains Japanese characters and clearly states "第２四半期報告書" (Second Quarter Report) and references the "金融商品取引法" (Financial Instruments and Exchange Act). It includes a confirmation statement by the CEO regarding the appropriateness of the content for the period covering August 1, 2024, to January 31, 2025. A comprehensive report for a period shorter than a year (half-year/quarterly) aligns directly with the definition of an Interim / Quarterly Report (IR). The document length is very short (571 chars), suggesting it might be a cover sheet or a summary confirmation related to the filing, but the core subject matter is the quarterly report itself, making IR the most appropriate classification over RPA or RNS, as it explicitly details the content verification for the semi-annual report.
2025-03-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.